Skip to content
Safety

Understanding Vascular Occlusion: A Practical Guide for Injectors

Recognising the early signs of vascular compromise and acting fast can make all the difference. Here is a structured approach every injector should know.

Vascular occlusion is one of the most serious complications associated with dermal filler treatments. While rare, it can occur in the hands of even the most experienced injectors — which is why every practitioner needs a clear, rehearsed plan for prevention, recognition and management.

Why it happens

Occlusion occurs when filler is injected into, or compresses, a blood vessel, reducing blood flow to the tissue it supplies. High-risk areas include the glabella, the nasal region, the nasolabial fold and the temples, where important vessels run superficially or have variable anatomy.

Prevention starts before the needle

  • Know the anatomy: understand the depth and course of facial arteries in every area you treat, and remember that anatomy varies between patients.
  • Choose the right tool: consider a blunt cannula in higher-risk zones where appropriate to the technique.
  • Inject slowly with low pressure: small aliquots, constant movement and minimal volume per pass reduce risk.
  • Be prepared: keep hyaluronidase, a written protocol and emergency contacts in every treatment room.

Recognising the warning signs

Early recognition is critical. Signs may appear immediately or be delayed by several hours:

  • Blanching or a mottled, net-like (livedo) pattern of the skin
  • Pain that is disproportionate to the procedure
  • Delayed capillary refill compared with surrounding skin
  • Later, a dusky or blue-grey discolouration and, eventually, pustules
If you suspect occlusion, stop injecting immediately. Time to treatment is the single most important factor in the outcome.

Managing a suspected occlusion

Management should follow a recognised, evidence-based complications protocol. This typically involves stopping the procedure, assessing the area, and — where a hyaluronic acid filler has been used — prompt treatment with hyaluronidase, repeated as necessary while monitoring perfusion. Visual symptoms are a medical emergency requiring immediate escalation.

Documentation and follow-up

Record everything: products, batch numbers, injection sites, the time symptoms were noticed and every action taken. Arrange close follow-up and ensure the patient knows exactly how to contact you.

How we teach it

At SD Academy, complication management is woven through every injectable programme — from anatomy lectures and case studies to simulated emergency drills on your practical training day. Our goal is simple: confident practitioners who keep patients safe.

This article is for educational purposes for qualified professionals and does not replace clinical judgement or official guidance.
SA
SD Academy Faculty
Medical aesthetics faculty at SD Academy
Learn it hands-on

Related courses